ArticleDrug design, development and therapy2019

Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3β pathway.

Ruiwei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.